Understanding frontotemporal dementia and its link to ALS

Expanding insights into FTD disease mechanisms

NIH-funded research Mayo Clinic Jacksonville · NIH-11241952

Researchers are using lab and translational work to learn why frontotemporal dementia and some forms of ALS happen, aiming to help people with FTD or ALS.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionMayo Clinic Jacksonville NIH-funded
Lab location1 site (Jacksonville, United States)
Project IDNIH-11241952 on NIH RePORTER

What this research studies

This program focuses on frontotemporal dementia (FTD) and the overlap with amyotrophic lateral sclerosis (ALS). The team studies key disease molecules—like C9orf72, TDP-43, progranulin, tau, and TMEM106B—using laboratory models and human samples to uncover how the disease starts and progresses. They are also working to discover biomarkers that could enable earlier diagnosis and to explore targets for new treatments. The approach mixes basic science discoveries with translational steps to move findings closer to clinical use.

Who could benefit from this research

Good fit: Ideal candidates would include people with a diagnosis of frontotemporal dementia, individuals with overlapping FTD-ALS symptoms, and people known to carry mutations linked to FTD such as C9orf72 or GRN who may want to contribute samples or join biomarker efforts.

Not a fit: People with unrelated types of dementia or neurological conditions that do not involve FTD/ALS biology are unlikely to benefit directly from this specific program.

Why it matters

Potential benefit: If successful, this work could produce biomarkers for earlier diagnosis and identify targets that lead to new treatments for FTD and related ALS cases.

How similar studies have performed: Related basic and translational research has produced important biological insights and candidate biomarkers, but no definitive disease-modifying treatments exist yet.

Where this research is happening

Jacksonville, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Amyotrophic Lateral Sclerosis Motor Neuron Disease
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.